Effect of prednisolone on IgE-dependent biphasic cutaneous reaction in BALB/c mice

General Pharmacology

Volumn 28, Issue 1, 1997, Pages 93-97

  Inagaki, Naoki ^a   Tsunematsu, Masako ^a   Sakurai, Toshimi ^a   Matsuo, Akihiko ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

biphasic cutaneous reaction; dinitrofluorobenzene; IgE; IL 1 ; late phase; prednisolone; TNF

Indexed keywords

ANTIGEN; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 1BETA ANTIBODY; MESSENGER RNA; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN EDEMA;

ANIMALS; ANTIBODIES, MONOCLONAL; DERMATITIS, ATOPIC; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; IMMUNOGLOBULIN E; INTERLEUKIN-1; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; PREDNISOLONE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031022274     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00166-8     Document Type: Article

References (26)

1. ∈RI). J. Exp. Med. 175, 1285-1290.
2. Björk J., Goldschmidt T., Smedegård G., Arfors K.-E. (1985) Methylprednisolone acts at the endothelial cell level reducing inflammatory responses. Acta Physiol. Scand. 123, 221-223.
3. Bonini S., Bonini S., Bucci M. G., Berruto A., Adriani E., Balsano F. and Allansmith M. R. (1990) Allergen dose response and late symptoms in a human model of ocular allergy. J. Allerg. Clin. Immunol. 86, 869-876.
4. Dolovich J., Hargreave F. E., Jordana M. and Denburg J. (1989) Late-phase airway reaction and inflammation. J. Allerg. Clin. Immunol. 83, 521-524.
5. Eisen H. N., Belman S. and Carsten M. E. (1953) The reaction of 2,4-dinitrobenzenesulfonic acid with free amino groups of proteins. J. Am. Chem. Soc. 75, 4583-4585.
6. Gordon J. R. and Galli S. J. (1990) Mast cells as a source of both preformed and immunologically inducible TNF-α / cachectin. Nature 346, 274-276.
7. ∈RI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biologic responses. J. Exp. Med. 174, 103-107.
8. Hargreave F. E. (1989) Late-phase asthmatic responses and airway inflammation. J. Allerg. Clin. Immunol. 83, 525-527.
9. Inagaki N., Miura T., Nagai H. and Koda A. (1988a) Inhibition of vascular permeability increase in mice. An additional anti-allergic mechanism of glucocorticoids. Int. Arch. Allerg. Appl. Immunol. 87, 254-259.
10. Inagaki N., Miura T., Nagai H. and Koda A. (1988b) Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats. Jpn. J. Pharmac. 46, 189-192.
11. Katayama I., Tanei R., Yokozeki H., Nishioka K. and Dohi Y. (1990) Induction of eczematous skin reaction in experimentally induced hyperplastic skin of BALB/c mice by monoclonal anti-DNP IgE antibody: possible implications for skin lesion formation in atopic dermatitis. Int. Arch. Allerg. Appl.Immunol. 93, 148-154.
12. Kay A. B., Ying S., Varney V., Gaga M., Durham S. R., Moqbel R., Wardlaw A. J. and Hamid Q. (1991) Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte / macrophage colony-stimulating factor, in allergen-induced late-phse cutaneous reactions in atopic subjects. J. Exp. Med. 173, 775-778.
13. Kupper T. S. (1989a) Mechanism of cutaneous inflammation. Arch. Dermatol. 125, 1406-1412.
14. Kupper T. S. (1989b) Production of cytokines by epithelial tissues. A new model for cutaneous inflammation. Am. J. Dermatopathol. 11, 69-73.
15. Nagai H., Sakamoto T., Inagaki N., Miura T. and Koda A. (1992) The effect of prednisolone on substance P-induced vascular permeability in mice. Agents Actions 35, 141-148.
16. v mice. Inflammation Res. (in press).
17. Nagai H., Sakurai T., Inagaki N. and Mori H. (1995) An immunopharmacological study of the biphasic allergic skin reaction in mice. Biol. Pharm. Bull. 18, 239-245.
18. 2 production by blocking mRNA synthesis and post-transcriptional expression. J. Biol. Chem. 265, 12745-12748.
19. Pelican Z. and Pelican-Filipek M. (1989) Cytologic changes in the nasal secretions during the late nasal response. J. Allerg. Clin. Immunol. 83, 1068-1079.
20. Ray M. C., Tharp M. D., Sullivan T. J. and Tigelaar R. E. (1983) Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies. J. Immunol 131, 1096-1102.
21. Sakurai T., Inagaki N. and Nagai H. (1994) The effect of anti-tumor necrosis factor (TNF)-α monoclonal antibody on allergic cutaneous late phase reaction in mice. Life Sci. 54, PL 291-295.
22. Sauder N. D. (1990) The role of epidermal cytokines in inflammatory skin diseases. J. Invest. Dermatol. 95(suppl.), 27-28.
23. Svensjö E. and Roempke K. (1985) Time-dependent inhibition of bradykinin and histamine-induced increase in microvascular permeability by local glucocorticoid treatment. In (Edited by Hogg J. C., Ellul-Micallef R. and Brattsand R.) pp. 136-144. Glucocorticoids, Inflammation and Bronchial Hyperreactivity. Excerpta Medica, Amsterdam.
24. ∈RI. J. Exp. Med. 175, 1353-1365.
25. Wershil B. K., Furuta G. T., Lavigne J. A., Choudhury A. R., Wang Z.-S. and Galli S. J. (1995) Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. J. Immunol. 154, 1391-1398.
26. Yasuda M., Kokubo F., Izumi H., Matsukura S., Tokunaga H., Yamamoto T., Kuroiwa Y. and Adachi M. (1995) Effect of dexamethasone on intercellular adhesion molecule-1 expression on cultured bronchial epithelial cells stimulated by inflammatory cytokines. Jpn. J. Allergol. 44, 100-103.